David Emerson Jorden, Director at CYTOMEDIX INC (CMXI), bought 50,000 shares at $0.53 ($27K) on 2013-02-22, disclosed to the SEC on 2013-02-22.
Open-market purchase of $26k CMXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.53 | 30,000 | $16K | 60.0% |
| 2 | $0.53 | 20,000 | $11K | 40.0% |
| Total | $0.53 avg | 50,000 | $27K | 100% |
| Filing → |
| AURX | BUY | 2017-08-14 | $54K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $450K | — | Filing → |
| PrivateNuo Therapeutics, Inc. | BUY | 2016-07-29 | $138K | — | Filing → |